Quick Heal Technologies Ltd Falls to 52-Week Low of Rs.164.8

2 hours ago
share
Share Via
Quick Heal Technologies Ltd has touched a new 52-week low of Rs.164.8 today, marking a significant decline amid a sustained downward trajectory. The stock has underperformed its sector and broader market indices, reflecting ongoing challenges in its financial performance and market positioning.
Quick Heal Technologies Ltd Falls to 52-Week Low of Rs.164.8

Stock Price Movement and Market Context

On 26 Feb 2026, Quick Heal Technologies Ltd’s share price declined by 1.67% to reach Rs.164.8, the lowest level recorded in the past year. This drop extends a three-day losing streak during which the stock has fallen by 10.17%. The stock’s performance today notably lagged behind the Software Products sector, underperforming by 1.81%. Furthermore, Quick Heal is trading below all key moving averages — the 5-day, 20-day, 50-day, 100-day, and 200-day — signalling persistent bearish momentum.

In contrast, the Sensex index, despite opening 142.71 points higher, closed lower by 301.94 points at 82,116.84, down 0.19%. The Sensex remains 4.92% below its 52-week high of 86,159.02 and is trading below its 50-day moving average, although the 50DMA remains above the 200DMA, indicating mixed signals for the broader market.

Long-Term and Recent Performance Metrics

Quick Heal Technologies Ltd’s one-year stock return stands at -50.23%, a stark contrast to the Sensex’s positive 10.07% return over the same period. The stock’s 52-week high was Rs.416, highlighting the extent of the decline. Over the last five years, the company has experienced negative growth trends, with net sales decreasing at an annualised rate of 1.02% and operating profit deteriorating by 178.20%. These figures underscore the company’s struggles to generate sustainable growth.

Profitability has also been under pressure, with profits falling by 74.2% over the past year. The company’s earnings before interest, taxes, depreciation, and amortisation (EBITDA) have been negative, contributing to the stock’s classification as risky relative to its historical valuation averages.

Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.

  • - Investment Committee approved
  • - 50+ candidates screened
  • - Strong post-announcement performance

See Why It Was Chosen →

Financial Ratios and Liquidity Concerns

The company’s debtor turnover ratio for the half-year period is notably low at 1.57 times, indicating slower collection of receivables. Cash and cash equivalents have also declined to Rs.6.84 crores, reflecting limited liquidity buffers. Additionally, non-operating income constitutes 155.65% of profit before tax (PBT) in the quarter, suggesting that core business profitability is weak and the company is relying on ancillary income streams to support earnings.

Despite these challenges, Quick Heal maintains a low average debt-to-equity ratio of zero, indicating minimal leverage. The majority shareholding remains with promoters, which may influence strategic decisions and capital allocation.

Comparative Performance and Market Position

Quick Heal Technologies Ltd has underperformed not only the Sensex but also the BSE500 index over the last three years, one year, and three months. This underperformance across multiple time frames highlights persistent difficulties in regaining investor confidence and market share within the Software Products sector.

The company’s Mojo Score currently stands at 26.0, with a Mojo Grade of Strong Sell as of 2 Dec 2025, downgraded from Sell. The Market Cap Grade is 3, reflecting a relatively modest market capitalisation compared to peers.

Is Quick Heal Technologies Ltd your best bet? SwitchER suggests better alternatives across peers, market caps, and sectors. Discover stocks that could deliver more for your portfolio!

  • - Better alternatives suggested
  • - Cross-sector comparison
  • - Portfolio optimization tool

Find Better Alternatives →

Summary of Key Concerns

The stock’s recent decline to Rs.164.8, its 52-week low, is the culmination of several factors including sustained negative returns, deteriorating profitability, and weak sales growth. The reliance on non-operating income to bolster profits and the low debtor turnover ratio point to challenges in core business operations and cash flow management. The negative EBITDA and significant profit contraction over the past year further compound the stock’s risk profile.

While the company’s low debt levels reduce financial risk, the overall performance metrics and market valuation trends indicate a cautious outlook. The stock’s consistent underperformance relative to sector peers and benchmark indices underscores the difficulties faced by Quick Heal Technologies Ltd in reversing its downtrend.

Market and Sector Overview

The Software Products sector, in which Quick Heal operates, has seen mixed performance recently. The sector’s relative outperformance compared to Quick Heal’s stock highlights the company’s specific challenges rather than broad sector weakness. The Sensex’s proximity to its 52-week high contrasts with Quick Heal’s significant share price erosion, emphasising the divergence in performance.

Shareholding and Corporate Structure

Promoters continue to hold the majority stake in Quick Heal Technologies Ltd, maintaining control over strategic decisions. The company’s capital structure remains conservative with negligible debt, which may provide some stability amid earnings volatility.

Conclusion

Quick Heal Technologies Ltd’s fall to a 52-week low of Rs.164.8 reflects a combination of subdued financial results, declining profitability, and persistent market underperformance. The stock’s current valuation and financial metrics indicate ongoing challenges in regaining momentum within the competitive Software Products sector. Investors and market participants will continue to monitor the company’s financial disclosures and market developments closely as it navigates this difficult phase.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News